TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
TruScreen Group Ltd. ( (AU:TRU) ) has provided an update.
TruScreen Group Limited has announced the dates for its Annual Shareholders’ Meeting and the director nominations period, with the meeting scheduled for September 11, 2025, and nominations closing on July 25, 2025. This announcement is part of the company’s ongoing governance and operational activities, reflecting its commitment to maintaining transparency and engagement with stakeholders. The company’s innovative cervical screening technology continues to gain recognition and adoption globally, enhancing its position in the medical device industry.
More about TruScreen Group Ltd.
TruScreen Group Limited is a medical device company specializing in AI-enabled cervical screening technology. Their primary product, the TruScreen Ultra, provides real-time detection of cervical tissue abnormalities without the need for traditional sampling and laboratory processing. The device is certified and approved for clinical use in multiple countries, including Australia, the UK, China, and Mexico, and is distributed in 29 countries. TruScreen has established a manufacturing facility in China and has been recognized in various national health guidelines.
Average Trading Volume: 503,032
Technical Sentiment Signal: Sell
Current Market Cap: A$12.63M
See more insights into TRU stock on TipRanks’ Stock Analysis page.